Results support use of tai chi for long term management of chronic insomnia in over 50s Tai chi, a form of mind-body exercise widely practiced in Chinese communities, has similar benefits to talking therapy for middle aged and older people with chronic insomnia, finds a trial from Hong Kong published by The BMJ today. These ...
Continued use leads to overall “net clinical benefit” say researchers Extending anti-clotting drugs beyond the initial treatment period of at least 90 days after a first blood clot is linked to lower rates of new clots developing compared with stopping treatment, finds a US study published by The BMJ today. Extended treatment ...
Yet UK and European drug regulators specify access to 2 adrenaline devices at all times Giving ‘spare’ devices to all schools would be safer and save local health bodies £millions Less than half of schoolchildren in England who are at risk of a serious and potentially life-threatening allergic reaction (anaphylaxis) ...
Replication in other populations and settings needed to confirm and extend these observations, say researchers Sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes are associated with an 11% lower risk of autoimmune rheumatic diseases, such as rheumatoid arthritis and lupus, compared with another group of diabetes drugs called ...
While it likely increases the risk of serious side effects, including heart disease Potential harms probably outweigh benefits, and use should be minimised, say researchers The strong opioid painkiller, tramadol, is not that effective at easing chronic pain for which it’s widely prescribed, finds a pooled data analysis of the ...
Over 200,000 patients may be eligible for treatment in the first three years, but some commissioners are already considering tighter prescribing criteria or rationing Figures confirm the fear that the roll out is not fit for purpose, says expert Less than half of England has access to tirzepatide (Mounjaro) through ...
Higher volume prescribers more likely to receive payments; and recipients more likely to prescribe that company’s drugs, especially if payments were larger, sustained, and recent Nearly 80% of US neurologists prescribing drugs for multiple sclerosis (MS) received at least one pharma industry payment, with higher volume prescribers more likely to ...
Experts alarmed by “outrageous” treatment claims for autism and diabetes Several claims to be reviewed by Advertising Standards Agency Parents are spending thousands of pounds to bank stem cells from their children’s milk teeth – but the recipient companies’ claims about their future medical value are unproven and potentially misleading, ...
Patients nearly 4 times more likely to recall being told of short rather than long-term memory loss and 6 times more likely to recall being told ECT can be life saving rather than about potential heart problems The medical pros of electroconvulsive therapy (ECT) are being exaggerated while the risks ...
Recommendations account for varied patient risk profiles and focus on weight loss effects, particularly of drugs of interest to adults with concomitant obesity SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher risk of cardiovascular and kidney ...
Copyright © 2025 BMJ Publishing Group Limited. All rights reserved.
Cookie settings | Accessibility | Cookie policy | Modern Slavery Statement | Privacy policy | Website terms and conditions
